Emerging Nonsteroid-Based Procedural Therapies for Alopecia Areata: A Systematic Review
CONCLUSION There is an abundance of evidence for nonsteroid-based procedural therapies in the treatment of AA. Randomized control trials comparing these treatment options head-to-head should be performed to better understand the true efficacy of these treatments.
The congresswoman from Massachusetts said that she was making peace with the condition in a video released on Thursday.
In a moving interview with The Root, Massachusetts Rep. Ayanna Pressley opened up about living with alopecia and revealed that she has gone completely bald. Pressley, 45, said she decided to go public about her hair loss because she felt she owed an explanation to all the women of color who have reached out to her about what had become known as her signature hairstyle: Senegalese twists. She added that she decided to open up about going bald “to be freed from the secret, and the shame that that secret carries with it.” “I’m not here just to occupy space,” she also said. “I’m here t...
ConclusionOur findings suggested different urinary polyamine, androgen, and bile acid concentrations between alopecia areata patients and normal controls. Additionally, levels of endogenous substances varied according to sex, and this should be considered when developing appropriate treatments and diagnostic techniques. Our findings improve our understanding of polyamine, androgen, and bile acid profiles in patients with alopecia areata and highlight the need to consider sex-related differences.
Condition: Alopecia Areata Interventions: Device: Carboxytherapy; Drug: Intralesional Steroid Injection Sponsor: Kasr El Aini Hospital Active, not recruiting
We present a case of alopecia areata possibly linked to the ingestion of amphetamines. This case may provide evidence that amphetamines can also be a cause of alopecia areata in susceptible individuals. We intend to awaken an interest in the medication history of patients presenting with sudden diffuse alopecia areata.
Khalil I Al-Hamdi, Anwar Qais SaadoonInternational Journal of Trichology 2019 11(6):244-246 Alopecic and aseptic nodules of the scalp (AANS) is a relatively new and little-known entity, and thus may possibly be underdiagnosed. This condition was first described in Japan by Iwata et al., in 1992. This disease occurs mainly in young males and is characterized by the presence of aseptic nodular scalp lesions associated with nonscarring alopecia that may resolve within 3 months. Here, we are reporting a case of AANS with a chronic relapsing course. To the best of our knowledge, this is the first case of this rare entity that ...
Jonghoon Kang, Erin KangInternational Journal of Trichology 2019 11(6):256-257
Abstract Belimumab, an anti-B-lymphocyte stimulator monoclonal antibody, was recently approved for the treatment of systemic lupus erythematosus. Alopecia areata is characterized by an acute immune-mediated hair loss. Herein, we report on three adult systemic lupus erythematosus patients who developed alopecia areata in association with belimumab treatment. Alopecia areata was resolved in all three patients and belimumab was discontinued in two of them. Thus, in the current report, we explore the plausible link between alopecia areata and belimumab. PMID: 31924144 [PubMed - as supplied by publisher]
Authors: Ismail FF, Sinclair R Abstract Introduction: Alopecia areata (AA) is a T-cell-mediated disease which produces circular patches of non-scarring hair loss and nail dystrophy. Current treatment options for AA are limited and often yield unsatisfactory results. Pharmacologic inhibition of the Janus kinase (JAK) enzyme family is regrowing hair and reversing nail dystrophy in a number of patients with hitherto refractory AA. The six JAK inhibitors which have been successful in treating AA are tofacitinib, ruxolitinib, baricitinib, CTP-543, PF-06651600 and PF-06700841.Areas covered: This review reports randomized...